MX2016004660A - Composiciones de peptido novedosas. - Google Patents
Composiciones de peptido novedosas.Info
- Publication number
- MX2016004660A MX2016004660A MX2016004660A MX2016004660A MX2016004660A MX 2016004660 A MX2016004660 A MX 2016004660A MX 2016004660 A MX2016004660 A MX 2016004660A MX 2016004660 A MX2016004660 A MX 2016004660A MX 2016004660 A MX2016004660 A MX 2016004660A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- peptides
- amino acids
- formula
- novel peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención proporciona, entre otras cosas, péptidos y composiciones novedosas para tratar una enfermedad.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361890056P | 2013-10-11 | 2013-10-11 | |
US201461940095P | 2014-02-14 | 2014-02-14 | |
PCT/US2014/058646 WO2015054006A2 (en) | 2013-10-11 | 2014-10-01 | Novel peptide compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2016004660A true MX2016004660A (es) | 2016-11-14 |
Family
ID=52813728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016004660A MX2016004660A (es) | 2013-10-11 | 2014-10-01 | Composiciones de peptido novedosas. |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP3054967A4 (es) |
JP (1) | JP2017501967A (es) |
KR (1) | KR20160065969A (es) |
CN (1) | CN105828831A (es) |
AU (1) | AU2014332346B2 (es) |
BR (1) | BR112016007816A2 (es) |
CA (1) | CA2926641A1 (es) |
CL (1) | CL2016000836A1 (es) |
IL (1) | IL244956B (es) |
MX (1) | MX2016004660A (es) |
RU (1) | RU2016112931A (es) |
SG (1) | SG11201602661PA (es) |
WO (1) | WO2015054006A2 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017150327A1 (ja) * | 2016-03-03 | 2017-09-08 | 不二製油グループ本社株式会社 | 神経栄養因子の脳内分泌促進するための食品添加用組成物 |
JP6983247B2 (ja) * | 2017-02-16 | 2021-12-17 | ケアジェン カンパニー, リミテッドCaregen Co., Ltd. | サリチル酸とペプチドとの結合体 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4244946A (en) | 1979-06-11 | 1981-01-13 | The Salk Institute For Biological Studies | Water-soluble peptides affecting gonadal function |
US4305872A (en) | 1979-10-19 | 1981-12-15 | Kenneth Wingrove | Polypeptide derivatives |
US4316891A (en) | 1980-06-14 | 1982-02-23 | The Salk Institute For Biological Studies | Extended N-terminal somatostatin |
WO1998002452A2 (en) | 1996-07-12 | 1998-01-22 | Mcgill University | Compounds and methods for modulating cell adhesion |
US20020168761A1 (en) | 2000-01-24 | 2002-11-14 | Gour Barbara J. | Peptidomimetic modulators of cell adhesion |
US7563862B2 (en) * | 2001-08-24 | 2009-07-21 | Neuren Pharmaceuticals Limited | Neural regeneration peptides and methods for their use in treatment of brain damage |
JP4399260B2 (ja) * | 2001-08-24 | 2010-01-13 | ニューレン ファーマシューティカルズ リミテッド | 神経再生ペプチドおよび脳損傷治療におけるその使用方法 |
AU2003293807A1 (en) * | 2002-12-24 | 2004-07-22 | Algonomics N.V. | Mhc class i restricted t-cell stimulating peptides from hepatitis b virus |
EP1685151A4 (en) * | 2003-10-31 | 2009-04-22 | Neuren Pharmaceuticals Ltd | NEURONAL REGENERATION OF PEPTIDES AND METHODS OF USE IN THE TREATMENT OF BRAIN DISORDERS |
WO2007011595A2 (en) * | 2005-07-15 | 2007-01-25 | Neuren Pharmaceuticals Limited | Neural regeneration peptides and antioxidants protect neurons from degeneration |
CA2804618C (en) * | 2010-07-09 | 2020-09-08 | Dana-Faber Cancer Institute, Inc. | Stabilized insulinotropic peptides and methods of use |
EP2819687A4 (en) * | 2012-02-10 | 2015-09-30 | Tarix Pharmaceuticals Ltd | COMPOSITIONS AND METHODS FOR TREATING PERIPHERAL VASCULAR DISEASE |
-
2014
- 2014-10-01 CA CA2926641A patent/CA2926641A1/en not_active Abandoned
- 2014-10-01 WO PCT/US2014/058646 patent/WO2015054006A2/en active Application Filing
- 2014-10-01 EP EP14852391.3A patent/EP3054967A4/en not_active Withdrawn
- 2014-10-01 BR BR112016007816A patent/BR112016007816A2/pt not_active Application Discontinuation
- 2014-10-01 SG SG11201602661PA patent/SG11201602661PA/en unknown
- 2014-10-01 JP JP2016521985A patent/JP2017501967A/ja active Pending
- 2014-10-01 RU RU2016112931A patent/RU2016112931A/ru not_active Application Discontinuation
- 2014-10-01 MX MX2016004660A patent/MX2016004660A/es unknown
- 2014-10-01 KR KR1020167011913A patent/KR20160065969A/ko not_active Application Discontinuation
- 2014-10-01 AU AU2014332346A patent/AU2014332346B2/en not_active Ceased
- 2014-10-01 CN CN201480066852.9A patent/CN105828831A/zh active Pending
-
2016
- 2016-04-06 IL IL24495616A patent/IL244956B/en not_active IP Right Cessation
- 2016-04-11 CL CL2016000836A patent/CL2016000836A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
KR20160065969A (ko) | 2016-06-09 |
EP3054967A2 (en) | 2016-08-17 |
CN105828831A (zh) | 2016-08-03 |
RU2016112931A (ru) | 2017-11-16 |
AU2014332346A1 (en) | 2016-05-05 |
BR112016007816A2 (pt) | 2017-12-05 |
CA2926641A1 (en) | 2015-04-16 |
EP3054967A4 (en) | 2017-04-19 |
RU2016112931A3 (es) | 2018-06-20 |
WO2015054006A2 (en) | 2015-04-16 |
CL2016000836A1 (es) | 2016-09-16 |
IL244956A0 (en) | 2016-05-31 |
WO2015054006A3 (en) | 2015-06-04 |
SG11201602661PA (en) | 2016-05-30 |
AU2014332346B2 (en) | 2019-01-24 |
IL244956B (en) | 2019-10-31 |
JP2017501967A (ja) | 2017-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017500866A1 (en) | Targeted xten conjugate compositions and methods of making same | |
PH12014501924A1 (en) | Xten conjugate compositions and methods of making same | |
MX2017015105A (es) | Compuestos del peptido yy (pyy) selectivos y sus usos. | |
MX2019000566A (es) | Suministro mediado por ve de conjugados de proteína de enlace-molécula pequeña. | |
MX2016006053A (es) | Compuestos selectivos de peptido yy (pyy) y usos de los mismos. | |
MY161773A (en) | Amylin analogues and pharmaceutical compositions thereof | |
BR112012029975A2 (pt) | peptídeo como medicamento, em particular para o tratamento do câncer. | |
RS53782B1 (en) | TUMOR-ASSOCIATED PEPTIDES PREPARED AND ANTI-CHANGE RESPONSE FOR GLIOBLASTOMA (GBM) AND OTHER CANCER TREATMENTS | |
MX362432B (es) | Variantes de oxm pegilada. | |
IN2013MU03583A (es) | ||
IN2014DN00101A (es) | ||
CY1119036T1 (el) | Νεοι αγωνιστες του υποδοχεα τυπου 2 της αγγειοτενσινης (ατ2) και χρησεις τους | |
PH12017501539A1 (en) | Disacetoxytubulysin h and analogs thereof | |
PH12019550241A1 (en) | Mic-1 compounds and uses thereof | |
EA201591752A1 (ru) | Дипептидные и трипептидные эпоксикетонные ингибиторы протеазы | |
TN2013000386A1 (en) | Suspension type topical formulations comprising cyclic depsipeptide | |
MX2020012989A (es) | Agente terapeutico para la fibrosis. | |
EA201590601A1 (ru) | Применение pedf-производных полипептидов для лечения остеоартрита | |
WO2015024022A3 (en) | Designed peptides for tight junction barrier modulation | |
NZ732301A (en) | Peptide compound, preparation method therefor, and application thereof | |
MX2016004660A (es) | Composiciones de peptido novedosas. | |
CL2021001479A1 (es) | Péptido; uso de composiciones; composición farmacéutica; uso de un anticuerpo para terapia; uso de un anticuerpo para elisa, inmunohistoquímica y/o formación de imágenes; receptor de linfocito t; y uso de un linfocito t citotóxico activado (divisional de la solicitud n° 201701391) | |
EA202191515A1 (ru) | Фармацевтическая композиция, содержащая апиксабан | |
BR112015022730A2 (pt) | formulações de rfviii, método para conjugação covalente de rfviii com um polímero biocompatível e uso de rfviii no preparo de formulação de rfviii para tratamento de hemofilia a | |
MX2015002279A (es) | Peptido pntx(19) sintético, composición farmacéutica.y uso. |